BZI-WIIM

PDS Biotechnology (NASDAQ:PDSB)  shares are trading higher after the company announced the release of the abstract for PDS0101 in the NCI-led Phase 2 clinical study for oral presentation at the 2021 ASCO meeting. PDS Biotechnology's stock is trading up 31.88% to a price of $7.15. The...

Youdao (NYSE:DAO) shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and announced a price target of $30 per share. Youdao is currently up 14.5% to a price of $25.7. The stock's volume is currently 742.41 thousand, which is roughly 268.24% of...

Iovance Biotherapeutics (NASDAQ:IOVA) shares are trading higher after the company announced Lifileucel achieved an 86% response rate in a melanoma trial. Iovance Biotherapeutics' stock is trading up 16.35% to a price of $18.79. Thursday the stock has been traded at a volume of 30.71...

I-MAB (NASDAQ:IMAB) shares are trading higher after the company showcased early data on Uliledlimab/Atezolizumab combination in advanced cancer settings. I-Mab's stock has been rising Thursday, up 10.59% to a price of $70.23. The stock's volume is currently 975.26 thousand, which...

Hormel Foods (NYSE:HRL) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also issued FY21 sales guidance above analyst estimates. Hormel Foods is currently up 7.79% to a price of $49.73. The stock's current volume for the day...

VistaGen Therapeutics (NASDAQ:VTGN) shares are trading higher after Baird initiated coverage on the stock with an Outperform rating and announced a price target of $9 per share. VistaGen Therapeutics' is currently up 12.6% to a price of $2.57. The stock's volume is currently 25.34...

Immutep (NASDAQ:IMMP) shares are trading higher after the company announced the publication of TACTI-002 and INSIGHT-004 abstracts for ASCO 2021 Annual Meeting. Immutep's stock has been rising Thursday, up 15.53% to a price of $4.7. The stock's volume is currently 7.24 million,...

Hims & Hers Health (NYSE:HIMS) shares are trading higher after Credit Suisse upgraded the stock from Neutral to Outperform. Hims & Hers Health's stock is trading up 6.06% to a price of $11.15. Thursday the stock has been traded at a volume of 808.40 thousand, about 59.64% of its...

GDS Holdings (NASDAQ:GDS) shares are trading lower after the company reported worse-than-expected Q1 sales results. GDS Holdings is currently down 7.91% to a price of $73.32. Thursday the stock has been traded at a volume of 1.98 million, about 134.8% of its recent 30-day volume average of 1....

Analog Devices (NASDAQ:ADI) shares are trading higher after Bernstein upgraded the stock from Market Perform to Outperform and raised its price target from $165 to $185 per share. Analog Devices' stock has been rising Thursday, up 4.66% to a price of $160.53. Thursday the stock has...

Inotiv (NASDAQ:NOTV) shares are trading higher after late Monday filings showed share purchases by multiple company executives. Inotiv's stock is trading up 22.58% to a price of $25.79. The stock's current volume for the day is 146.08 thousand, which is approximately 122.45% of...

Blade Air Mobility (NASDAQ:BLDE) shares are trading higher after the company reported Q1 sales results up from last year. Blade Air Mobility is currently up 13.86% to a price of $8.55. Tuesday the stock has been traded at a volume of 1.82 million, about 180.34% of its recent 30-day volume average...

Luna Innovations (NASDAQ:LUNA) shares are trading lower after the company reported worse-than-expected Q1 EPS and sales results. Luna Innovations is currently down 13.68% to a price of $10.16. The stock's volume is currently 489.99 thousand, which is roughly 314.08% of its recent 30-day...

PAVmed (NASDAQ:PAVM) shares are trading higher after the company reported better-than-expected Q1 EPS results. PAVmed is currently up 7.59% to a price of $4.28. The stock's volume is currently 2.48 million, which is roughly 68.15% of its recent 30-day volume average of 3.64 million. The...

Evofem Biosciences (NASDAQ:EVFM) shares are trading lower after the company priced its 50 million shares common stock offering at $1 per share. Evofem Biosciences' stock has been falling Tuesday, down 35.86% to a price of $0.82. Tuesday the stock has been traded at a volume of 84.68...